Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide.

Kishimoto W, Takiuchi Y, Nakae Y, Tabata S, Fukunaga A, Matsuzaki N, Yuba Y, Kitano T, Arima N.

Int J Hematol. 2019 Apr;109(4):499-504. doi: 10.1007/s12185-018-02587-6. Epub 2019 Jan 2.

PMID:
30604313
2.

B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.

Arima H, Nishikori M, Otsuka Y, Kishimoto W, Izumi K, Yasuda K, Yoshimoto T, Takaori-Kondo A.

Blood Adv. 2018 Sep 25;2(18):2282-2295. doi: 10.1182/bloodadvances.2018019919.

3.

Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma.

Arima H, Fujimoto M, Nishikori M, Kitano T, Kishimoto W, Hishizawa M, Kondo T, Yamashita K, Hirata M, Haga H, Takaori-Kondo A.

Leuk Lymphoma. 2018 Sep;59(9):2085-2095. doi: 10.1080/10428194.2017.1410884. Epub 2017 Dec 18.

PMID:
29251015
4.

Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy.

Nakae Y, Hyuga M, Terada Y, Kishimoto W, Fukunaga A, Tabata S, Maesako Y, Komatsu K, Higuchi O, Nakane T, Arima N.

Intern Med. 2017 Dec 15;56(24):3347-3351. doi: 10.2169/internalmedicine.9096-17. Epub 2017 Oct 11.

5.

Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban.

Tsuruya Y, Nakanishi T, Komori H, Wang X, Ishiguro N, Kito T, Ikukawa K, Kishimoto W, Ito S, Schaefer O, Ebner T, Yamamura N, Kusuhara H, Tamai I.

J Pharm Sci. 2017 Sep;106(9):2524-2534. doi: 10.1016/j.xphs.2017.04.044. Epub 2017 Apr 26.

PMID:
28456731
6.

Expression of Tim-1 in primary CNS lymphoma.

Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A.

Cancer Med. 2016 Nov;5(11):3235-3245. doi: 10.1002/cam4.930. Epub 2016 Oct 5.

7.
8.

Usefulness of A Model-Based Approach for Estimating In Vitro P-Glycoprotein Inhibition Potency in a Transcellular Transport Assay.

Kishimoto W, Ishiguro N, Ludwig-Schwellinger E, Ebner T, Maeda K, Sugiyama Y.

J Pharm Sci. 2016 Feb;105(2):891-896. doi: 10.1016/j.xphs.2015.11.006.

PMID:
26869433
9.

Sex-, Species-, and Tissue-Specific Metabolism of Empagliflozin in Male Mouse Kidney Forms an Unstable Hemiacetal Metabolite (M466/2) That Degrades to 4-Hydroxycrotonaldehyde, a Reactive and Cytotoxic Species.

Taub ME, Ludwig-Schwellinger E, Ishiguro N, Kishimoto W, Yu H, Wagner K, Tweedie D.

Chem Res Toxicol. 2015 Jan 20;28(1):103-15. doi: 10.1021/tx500380t. Epub 2015 Jan 5.

PMID:
25489797
10.

Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.

Fuchs H, Kishimoto W, Gansser D, Tanswell P, Ishiguro N.

Drug Metab Dispos. 2014 Oct;42(10):1761-5. doi: 10.1124/dmd.114.058545. Epub 2014 Jul 22.

PMID:
25053619
11.

Molecular pathogenesis of follicular lymphoma.

Kishimoto W, Nishikori M.

J Clin Exp Hematop. 2014;54(1):23-30. Review.

12.

In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 threshold.

Kishimoto W, Ishiguro N, Ludwig-Schwellinger E, Ebner T, Schaefer O.

Drug Metab Dispos. 2014 Feb;42(2):257-63. doi: 10.1124/dmd.113.053769. Epub 2013 Nov 8.

PMID:
24212378
13.

Impact of endogenous esterase activity on in vitro p-glycoprotein profiling of dabigatran etexilate in Caco-2 monolayers.

Ishiguro N, Kishimoto W, Volz A, Ludwig-Schwellinger E, Ebner T, Schaefer O.

Drug Metab Dispos. 2014 Feb;42(2):250-6. doi: 10.1124/dmd.113.053561. Epub 2013 Nov 8.

PMID:
24212377
14.

Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods.

Ishiguro N, Shimizu H, Kishimoto W, Ebner T, Schaefer O.

Drug Metab Dispos. 2013 Jan;41(1):149-58. doi: 10.1124/dmd.112.048470. Epub 2012 Oct 16.

PMID:
23073734
15.

Double-hit lymphoma with a feature of follicular lymphoma concurrent with clonally related B lymphoblastic leukemia : a preference of transformation for the bone marrow.

Kishimoto W, Shirase T, Chihara D, Maeda T, Arimoto-Miyamoto K, Takeoka T, Tsuji M, Ohno T, Kita K.

J Clin Exp Hematop. 2012;52(2):113-9.

16.

Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes.

Chompoo J, Upadhyay A, Kishimoto W, Makise T, Tawata S.

Food Chem. 2011 Dec 1;129(3):709-15. doi: 10.1016/j.foodchem.2011.04.034. Epub 2011 Apr 20.

PMID:
25212289
17.

Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, Ebner T, Terasaki T.

Drug Metab Dispos. 2012 Jan;40(1):83-92. doi: 10.1124/dmd.111.042259. Epub 2011 Oct 12.

PMID:
21994437
18.

HIV-1 integrase and neuraminidase inhibitors from Alpinia zerumbet.

Upadhyay A, Chompoo J, Kishimoto W, Makise T, Tawata S.

J Agric Food Chem. 2011 Apr 13;59(7):2857-62. doi: 10.1021/jf104813k. Epub 2011 Feb 9.

PMID:
21306110
19.

Progressive multifocal leukoencephalopathy in myelodysplastic syndrome involving pure red cell aplasia.

Chihara D, Takeoka T, Shirase T, Kishimoto W, Arimoto-Miyamoto K, Tsuji M, Ohno T.

Intern Med. 2010;49(21):2347-52. Epub 2010 Nov 1.

20.

Refractory Evans syndrome after autologous stem cell transplantation for multiple myeloma: management with a second transplantation.

Chihara D, Sakamoto T, Arimoto-Miyamoto K, Kishimoto W, Takeoka T, Tsuji M, Ohno T.

Intern Med. 2010;49(7):683-7. Epub 2010 Apr 1.

21.

CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock.

Isojima Y, Nakajima M, Ukai H, Fujishima H, Yamada RG, Masumoto KH, Kiuchi R, Ishida M, Ukai-Tadenuma M, Minami Y, Kito R, Nakao K, Kishimoto W, Yoo SH, Shimomura K, Takao T, Takano A, Kojima T, Nagai K, Sakaki Y, Takahashi JS, Ueda HR.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15744-9. doi: 10.1073/pnas.0908733106. Epub 2009 Sep 2.

22.

Epstein-Barr virus-induced infectious mononucleosis after two separate episodes of virus-associated hemophagocytic syndrome.

Ohno T, Ueda Y, Kishimoto W, Arimoto-Miyamoto K, Takeoka T, Tsuji M.

Intern Med. 2009;48(13):1169-73. Epub 2009 Jul 1.

23.

First case report of sepsis caused by Mycobacterium wolinskyi in chronic myelogenous leukemia.

Ohno T, Kishimoto W, Chihara D, Sakamoto T, Arimoto-Miyamoto K, Takeoka T, Tsuji M, Kida K, Ohkusu K, Ezaki T.

Diagn Microbiol Infect Dis. 2008 Dec;62(4):433-6. doi: 10.1016/j.diagmicrobio.2008.07.017. Epub 2008 Oct 16.

PMID:
18929459
24.

[Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia].

Tanaka Y, Kondo T, Kishimoto W, Kanda J, Tashima M, Mizumoto C, Ichinohe T, Ishikawa T, Uchiyama T, Haga H, Manabe T.

Rinsho Ketsueki. 2008 Apr;49(4):263-9. Japanese.

PMID:
18516870
25.

Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.

Ishiguro N, Maeda K, Saito A, Kishimoto W, Matsushima S, Ebner T, Roth W, Igarashi T, Sugiyama Y.

Drug Metab Dispos. 2008 Apr;36(4):796-805. doi: 10.1124/dmd.107.018903. Epub 2008 Jan 7.

PMID:
18180273
26.

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.

Ishiguro N, Maeda K, Kishimoto W, Saito A, Harada A, Ebner T, Roth W, Igarashi T, Sugiyama Y.

Drug Metab Dispos. 2006 Jul;34(7):1109-15. Epub 2006 Apr 12.

PMID:
16611857
27.

CYP2D in the brain.

Funae Y, Kishimoto W, Cho T, Niwa T, Hiroi T.

Drug Metab Pharmacokinet. 2003;18(6):337-49.

28.

Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.

Ishiguro N, Nozawa T, Tsujihata A, Saito A, Kishimoto W, Yokoyama K, Yotsumoto T, Sakai K, Igarashi T, Tamai I.

Drug Metab Dispos. 2004 May;32(5):519-24.

PMID:
15100174
29.

Regulation of CYP2D expression in rat brain by toluene.

Mizuno D, Hiroi T, Ng P, Kishimoto W, Imaoka S, Funae Y.

Osaka City Med J. 2003 Jun;49(1):49-56.

PMID:
14703099
30.

Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain.

Kishimoto W, Hiroi T, Shiraishi M, Osada M, Imaoka S, Kominami S, Igarashi T, Funae Y.

Endocrinology. 2004 Feb;145(2):699-705. Epub 2003 Oct 16.

PMID:
14563706
31.

Progesterone oxidation by cytochrome P450 2D isoforms in the brain.

Hiroi T, Kishimoto W, Chow T, Imaoka S, Igarashi T, Funae Y.

Endocrinology. 2001 Sep;142(9):3901-8.

PMID:
11517168
32.

Quantitative prediction of in vivo drug interactions between nevirapine and antifungal agents from in vitro data in rats.

Kishimoto W, Takano J, Senda C, Ishiguro N, Sakai K, Igarashi T.

Biol Pharm Bull. 2000 Sep;23(9):1027-32.

PMID:
10993198
33.

Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes.

Ishiguro N, Senda C, Kishimoto W, Sakai K, Funae Y, Igarashi T.

Xenobiotica. 2000 Jan;30(1):71-80.

PMID:
10659952
34.

Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine.

Kishimoto W, Hiroi T, Sakai K, Funae Y, Igarashi T.

Res Commun Mol Pathol Pharmacol. 1997 Dec;98(3):273-92.

PMID:
9485522
35.

Identification of human cytochrome P450 isoforms involved in the metabolism of brotizolam.

Senda C, Kishimoto W, Sakai K, Nagakura A, Igarashi T.

Xenobiotica. 1997 Sep;27(9):913-22.

PMID:
9381732
36.
37.

The involvement and sources of active oxygen in experimentally induced acute pancreatitis.

Ito T, Nakao A, Kishimoto W, Nakano M, Takagi H.

Pancreas. 1996 Mar;12(2):173-7.

PMID:
8720665
38.

Detection of O2- generation and neutrophil accumulation in rat lungs after acute necrotizing pancreatitis.

Murakami H, Nakao A, Kishimoto W, Nakano M, Takagi H.

Surgery. 1995 Sep;118(3):547-54.

PMID:
7652692
39.

Detection of superoxide free radicals in rats with acute pancreatitis.

Kishimoto W, Nakao A, Nakano M, Takahashi A, Inaba H, Takagi H.

Pancreas. 1995 Aug;11(2):122-6.

PMID:
7479667
40.

Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis.

Inoue S, Nakao A, Kishimoto W, Murakami H, Itoh K, Itoh T, Harada A, Nonami T, Takagi H.

Arch Surg. 1995 Jan;130(1):93-8.

PMID:
7802585
41.

Heparin effects on superoxide production by neutrophils.

Itoh K, Nakao A, Kishimoto W, Takagi H.

Eur Surg Res. 1995;27(3):184-8.

PMID:
7781656
42.

Prognosis of cancer of the duodenal papilla of Vater in relation to clinicopathological tumor extension.

Nakao A, Harada A, Nonami T, Kishimoto W, Takeda S, Ito K, Takagi H.

Hepatogastroenterology. 1994 Feb;41(1):73-8.

PMID:
8175122
43.

Decreased production of active oxygen species by neutrophils in patients with liver cirrhosis and hepatocellular carcinoma.

Itoh K, Nakao A, Kishimoto W, Itoh T, Harada A, Nonami T, Nakano M, Takagi H.

Gastroenterol Jpn. 1993 Aug;28(4):541-6.

PMID:
8397132
44.

The ability of polymorphonuclear leukocytes to produce active oxygen in a model of peritonitis in rats.

Shen SC, Nakao A, Kishimoto W, Harada A, Nonami T, Nakano M, Takagi H.

Surg Today. 1993;23(7):603-8.

PMID:
8396470
45.

13C-labeled trioctanoin breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy.

Kato H, Nakao A, Kishimoto W, Nonami T, Harada A, Hayakawa T, Takagi H.

Am J Gastroenterol. 1993 Jan;88(1):64-9.

PMID:
8093586
46.

[Long-term results of terminal esophago-proximal gastrectomy for esophageal varices].

Harada A, Nonami T, Nakao A, Kishimoto W, Murakami H, Takagi H.

Nihon Geka Gakkai Zasshi. 1992 Sep;93(9):1169-72. Japanese.

PMID:
1470137
47.

[The results and problems of surgical treatment of cancer of the duodenal papilla of Vater].

Nakao A, Harada A, Nonami T, Kishimoto W, Takeda S, Kurokawa T, Takagi H.

Nihon Geka Gakkai Zasshi. 1992 Aug;93(8):805-10. Japanese.

PMID:
1359393
48.

Inhibition by cyclosporine of the production of superoxide radicals.

Kurokawa T, Nonami T, Kobayashi H, Kishimoto W, Uchida K, Takagi H, Sugiyama S, Ozawa T.

N Engl J Med. 1992 Mar 19;326(12):840. No abstract available.

PMID:
1311414
49.

Results of hepatic resection and postoperative arterial chemotherapy for hepatocellular carcinoma.

Harada A, Nonami T, Kishimoto W, Nakao A, Takagi H.

Cancer Chemother Pharmacol. 1992;31 Suppl:S35-7.

PMID:
1333906
50.

[The significance of extent of resection in the treatment of hepatoma].

Nonami T, Kishimoto W, Harada A, Nakao A, Takagi H.

Nihon Geka Gakkai Zasshi. 1991 Nov;92(11):1602-7. Japanese.

PMID:
1663209

Supplemental Content

Loading ...
Support Center